Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21330598 | 0.86 | P2RX4 (0.53) | KMT2AMAPTKDM4ELMNAHTT | |
| SCHEMBL24547656 | 0.83 | ELANE (0.46) | ELANEKMT2AMAPTKDM4ELMNA | |
| SCHEMBL24547747 | 0.75 | POLB (0.46) | KMT2AMAPTKDM4ELMNAHTT | |
| SCHEMBL20139098 | 0.73 | LMNA (0.55) | ELANEKMT2AMAPTKDM4ELMNA | |
| SCHEMBL21330594 | 0.71 | P2RX4 (0.54) | ELANEKMT2AMAPTLMNAHTT | |
| SCHEMBL24547737 | 0.69 | LMNA (0.50) | ELANEKMT2AMAPTKDM4ELMNA | |
| SCHEMBL24547678 | 0.69 | ELANE (0.42) | ELANEKDM4ELMNAHTTMAPK1 | |
| SCHEMBL24547742 | 0.68 | P2RX4 (0.56) | ELANEKMT2AMAPTKDM4ELMNA | |
| SCHEMBL24547736 | 0.68 | ELANE (0.52) | ELANEPARP1HPGDCES2CES1 | |
| SCHEMBL27921481 | 0.66 | TRPV1 (0.41) | MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067654-A1 | OXYTOCIN RECEPTOR MODULATORS | Kinoxis Therapeutics Pty Ltd (AU) | 2024-02-29 | — | — | US | disclosed |
| US-20240067654-A1 | OXYTOCIN RECEPTOR MODULATORS | Kinoxis Therapeutics Pty Ltd (AU) | 2024-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067654-A1 | OXYTOCIN RECEPTOR MODULATORS | OXTR, AVPR1B, AVPR1A | ELANE 3651/4885KMT2A 4547/4885MAPT 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.